Target intelligence / Profile preview

Mucosal Immunity Induction via Intranasal Administration (Intranasal Mucosal Immunity)

Target
Intranasal Mucosal Immunity
Molecular classification
Immunological Process, Vaccination Strategy, Drug Delivery Method
01

Overview

Induction of mucosal immunity via intranasal administration is a vaccination strategy that delivers antigens through the nasal route to stimulate immune responses at mucosal surfaces, particularly in the respiratory tract. This approach aims to generate both local (mucosal) and systemic immunity, providing protection at the primary entry point for many pathogens. It relies on the activation of NALT, production of secretory IgA, and induction of tissue-resident memory cells.

Other names
Intranasal VaccinationNasal Vaccine DeliveryMucosal Vaccine AdministrationNALT-targeted Immunity
02

Mechanism of action

Antigen presentation in NALT, activation of B and T cells, production of secretory IgA, induction of tissue-resident memory cells.

03

Biological functions

Immune Response StimulationAntibody Production (IgA)T cell ActivationB cell ActivationMucosal DefenseSystemic ImmunityInduction of Tissue-resident Memory Cells
04

Disease associations

Prevention of Respiratory InfectionsPrevention of Mucosal InfectionsInfluenza PreventionCOVID-19 PreventionInfectious Disease Prevention
05

Safety considerations

Potential immunopathology due to formulationAdjuvant toxicityOff-target effects
06

Interacting drugs

FluMist (Influenza Vaccine)

2 more in the full profile.

07

Biomarkers

Secretory IgA levels in nasal secretionsCirculating IgG/IgA antibody titersNumber of tissue-resident memory T cells in lungs and airways

Beyond the preview

Go deeper on Mucosal Immunity Induction via Intranasal Administration (Intranasal Mucosal Immunity).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucosal Immunity Induction via Intranasal Administration (Intranasal Mucosal Immunity).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call